News & Updates

Show Multimedia Only
Dog owners ward off asthma against risk allele carriers Dog owners ward off asthma against risk allele carriers

Dog owners ward off asthma against risk allele carriers

29 Oct 2022

Among individuals carrying the 17q12-21 asthma-risk variant rs2305480, owning a dog appears to exert a protective effect against persistent wheeze, a recent study has found.

29 Oct 2022
Carbapenem-sparing cephamycins effective in E coli-induced UTI

Carbapenem-sparing cephamycins effective in E coli-induced UTI

28 Oct 2022 byJairia Dela Cruz

Cefmetazole and cefoxitin prove to be effective in the treatment of patients with urinary tract infections (UTIs) due to extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli, according to two separate studies presented at IDWeek 2022.

28 Oct 2022
Cemiplimab shows favourable signals as first-, second-line treatment alternative for NSCLC

Cemiplimab shows favourable signals as first-, second-line treatment alternative for NSCLC

28 Oct 2022 byAudrey Abella

In the 3-year follow-up of the EMPOWER-Lung 1 study, first-line cemiplimab continued to outdo chemotherapy (CT) in providing survival benefit for patients with advanced non-small-cell lung cancer (NSCLC). Moreover, in the second-line setting (patients with progressive disease [PD]), cemiplimab added to CT provided meaningful and durable objective response rate (ORR) and overall survival (OS) benefit.

28 Oct 2022
COVID-19 worsens antibiotic resistance

COVID-19 worsens antibiotic resistance

28 Oct 2022 byTristan Manalac

While rare, infection with antibiotic-resistant gram-negative bacteria (AR-GNB) following a positive COVID-19 diagnosis is more severe and often results in worse outcomes, according to a study presented at the recent Virtual ID Week 2022.

28 Oct 2022